Document Page: First | Prev | Next | All | Image | This Release | Search
File: aabjd_02.txtC. MEDICAL PERSONNEL EXPECTING TO HAVE BLOOD AND SALIVA EXPOSURE WILL RECEIVE AT LEAST ONE DOSE OF HEPATITIS B VACCINE UNLESS THE THREE-DOSE SERIES HAS ALREADY BEEN COMPLETED. D. MENINGCOCCAL VACCINE IS NOT REQUIRED BUT IS RECOMMENDED IF PRO- LONGED CLOSE CONTACT WITH LOCAL NATIONAL CITIZENS, ESPECIALLY CHILDREN, IS ANTICIPATED. PERSONNEL EXPECTING TO WORK IN REFUGEE CAMPS SHOULD BE VACCINATED. 3. MALARIA PROPHYLAXIS: A. CHLOROQUINE IS ONLY REQUIRED FOR PERSONNEL EXPECTING TO BE PRESENT FOR AT LEAST 5 CONSECUTIVE DAYS IN THE FOLLOWING AREAS DURING RISK PERIODS: {1} OMAN, YEAR ROUND; {2} JIZAN PROVINCE OF SAUDI ARABIA {NOT INCLUDING KHAMIS MUSHAIT}, YEAR ROUND; {3} DAHUK, NIMAWA, IRBIL AND AS SULAYMANIYAH PROVINCES OF IRAQ {ALL NORTHERN PROVINCES} MAY TO NOVEMBER; {4} RURAL AREAS IN SOUTHEAST TURKEY AND ALONG THE MEDITERRANEAN COAST, EAST OF ANTALYA, FEBRUARY TO NOVEMBER. B. AVOIDANCE OF MOSQUITO BITES IS THE PREFERRED METHOD OF MALARIA PREVENTION. PERSONAL PROTECTIVE MEASURES INCLUDE PROPER WEAR OF THE BATTLE DRESS UNIFORM, USE OF INSECT REPELLENTS, AND TREATMENT OF THE BATTLE DRESS UNIFORM, BEDNETS AND TENTAGE WITH THE RECENTLY APPROVED PERMETHRIN SPRAY {NSN 6840-01-334-2666}. CHLOROQUINE IS THE
Document Page: First | Prev | Next | All | Image | This Release | Search